vimarsana.com

Page 17 - ஏற்ற சினை பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Anthony L Pucillo, MD is recognized by Continental Who s Who

Share this article Share this article CHAPPAQUA, N.Y., March 9, 2021 /PRNewswire/ Anthony L. Pucillo, MD is being recognized by Continental Who s Who as a Top Doctor for his outstanding dedication in the field of Medicine and for his professional excellence with Columbia University.  (PRNewsfoto/Continental Who s Who) Having maintained a commendable reputation for his impact in medicine and academics, Dr. Anthony L. Pucillo has accrued nearly 40 years of professional excellence as a top cardiologist. He is currently serving as an assistant professor in the Division of Cardiology at Columbia University Medical Center. He practices at Columbia Doctors Medical Group in Hawthorne and White Plains. Dr. Pucillo also serves as the Director of Cardiac Operations at NYP/Lawrence Hospital. His clinical practice deals primarily with coronary artery disease and peripheral arterial disease and highlights his vast repertoire of expertise in cardiac catheterization, interventional cardiology

Researchers find new way to prevent attention deficits associated with Fragile X syndrome

Researchers find new way to prevent attention deficits associated with Fragile X syndrome Mount Sinai Researchers find a new way to prevent attention deficits associated with Fragile X, a leading genetic cause of autism, in an animal model. Corresponding author: Hirofumi Morishita, MD, Ph.D., Department of Psychiatry, Neuroscience, Friedman Brain Institute, Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York. Bottom line: The adolescent maturation of the frontal cortex is important for establishing cognitive function, and disruption of this process is associated with neurodevelopmental disorders. This study uncovered a new molecular driver of frontal circuit maturation that is essential for cognitive function, and demonstrated, in an animal model, that this mechanism can be targeted to restore attention deficits caused by a leading genetic cause of autism.

Timothy Mastro, MD, DTM&H

Clinical trials design and implementation Dr. Timothy Mastro serves as FHI 360’s Chief Science Officer, responsible for advancing the quality of science across the organization and growing research and evaluation capabilities in both the natural and social sciences. His work at FHI 360 has included clinical trials; epidemiology; global health research; COVID-19 vaccines and prevention; HIV prevention, care and treatment; tuberculosis; reproductive health; contraceptive technology; nutrition; implementation science; and programs addressing integrated development. Prior to joining FHI 360 in 2008, Mastro served in scientific leadership positions at the U.S. Centers for Disease Control and Prevention (CDC) for 20 years. His research and work in programs at CDC’s Division of HIV/AIDS Prevention and Global AIDS Program addressed the prevention and treatment of HIV, vaccine trials, sexually transmitted infections and tuberculosis. Mastro first joined CDC as an Epidemic Intelligence

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.